Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 2 , Pages 161-165 , April 2009

B-Type Natriuretic Peptide as a Predictor of Postoperative Heart Failure After Aortic Valve Replacement

  • Shahab Nozohoor, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Lund University Hospital, Lund, Sweden
    • Corresponding Author InformationAddress reprint requests to Shahab Nozohoor, MD, Department of Cardiothoracic Surgery, Heart and Lung Division, Lund University Hospital, SE-221 85 Lund, Sweden
    • ,
  • Johan Nilsson, MD, PhD

      Affiliations

    • Department of Cardiothoracic Surgery, Lund University Hospital, Lund, Sweden
    • ,
  • Carsten Lührs, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Lund University Hospital, Lund, Sweden
    • ,
  • Anders Roijer, MD, PhD

      Affiliations

    • Department of Cardiology, Lund University Hospital, Lund, Sweden
    • ,
  • Lars Algotsson, MD, PhD

      Affiliations

    • Department of Cardiothoracic Anesthesia, Lund University Hospital, Lund, Sweden
    • ,
  • Johan Sjögren, MD, PhD

      Affiliations

    • Department of Cardiothoracic Surgery, Lund University Hospital, Lund, Sweden

References 

  1. Lung B, Baron G, Tornos P, et al. Valvular heart disease in the community: A European experience. Curr Probl Cardiol. 2007;32:609–661
  2. Maganti MD, Rao V, Borger MA, et al. Predictors of low cardiac output syndrome after isolated aortic valve surgery. Circulation. 2005;30(suppl):I–448112
  3. Vanky FB, Hakanson E, Svedjeholm R. Long-term consequences of postoperative heart failure after surgery for aortic stenosis compared with coronary surgery. Ann Thorac Surg. 2007;83:2036–2043
  4. Vanky FB, Hakanson E, Tamas E, et al. Risk factors for postoperative heart failure in patients operated on for aortic stenosis. Ann Thorac Surg. 2006;81:1297–1304
  5. Stout KK, Otto CM. Indications for aortic valve replacement in aortic stenosis. J Intensive Care Med. 2007;22:14–25
  6. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: A Report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463
  7. Hare JL, Brown JK, Marwick TH. Performance of conventional echocardiographic parameters and myocardial measurements in the sequential evaluation of left ventricular function. Am J Cardiol. 2008;101:706–711
  8. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357–2368
  9. Morrow DA, de Lemos JA, Blazing MA, et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA. 2005;294:2866–2871
  10. Masson S, Latini R, Anand IS, et al. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: The Valsartan Heart Failure (Val-HeFT) data. Clin Chem. 2006;52:1528–1538
  11. Woodard GE, Rosado JA. Recent advances in natriuretic peptide research. J Cell Mol Med. 2007;11:1263–1271
  12. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014–1021
  13. Jogia PM, Kalkoff M, Sleigh JW, et al. NT-pro BNP secretion and clinical endpoints in cardiac surgery intensive care patients. Anaesth Intensive Care. 2007;35:363–369
  14. Provenchere S, Berroeta C, Reynaud C, et al. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: Association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med. 2006;34:995–1000
  15. Hutfless R, Kazanegra R, Madani M, et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol. 2004;43:1873–1879
  16. Edmunds J, Clark RE, Cohn LH, et al. Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg. 1996;112:708–711
  17. Morimoto K, Mori T, Ishiguro S, et al. Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surg Today. 1998;28:23–29
  18. Higgins TL, Estafanous FG, Loop FD, et al. ICU admission score for predicting morbidity and mortality risk after coronary artery bypass grafting. Ann Thorac Surg. 1997;64:1050–1058
  19. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics. 1988;44:837–845
  20. Schemper M, Smith TL. Efficient evaluation of treatment effects in the presence of missing covariate values. Stat Med. 1990;9:777–784
  21. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol. 2001;37:379–385
  22. Berendes E, Schmidt C, Van Aken H, et al. A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth Analg. 2004;98:11–19
  23. Skidmore KL, Russell IA. Brain natriuretic peptide: A diagnostic and treatment hormone for perioperative congestive heart failure. J Cardiothorac Vasc Anesth. 2004;18:780–787
  24. Han MK, McLaughlin VV, Criner GJ, et al. Pulmonary diseases and the heart. Circulation. 2007;116:2992–3005
  25. Passino C, Maria Sironi A, Favilli B, et al. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. Int J Cardiol. 2005;104:39–45

PII: S1053-0770(08)00352-2

doi: 10.1053/j.jvca.2008.11.006

Journal of Cardiothoracic and Vascular Anesthesia
Volume 23, Issue 2 , Pages 161-165 , April 2009

Article Tools

* Image Usage & Resolution